Michael Scott Robeson
Associate Professor
faculty
Biomedical Informatics, College of Medicine
Research Areas
Biography and Research Information
OverviewAI-generated summary
Michael Scott Robeson's research focuses on the intersection of biomedical informatics and health sciences, particularly investigating immune responses and microbiome diversity. He has contributed to studies examining immune responses in a phase 2 clinical trial for a human papillomavirus vaccine in patients with cervical intraepithelial neoplasia. Additionally, his work includes an analysis of gut microbiome diversity and composition changes following allogeneic hematopoietic stem cell transplant. Robeson's scholarly output includes six publications with a total of six citations and an h-index of 1. He has collaborated with researchers from the University of Arkansas for Medical Sciences, including David W. Ussery, William W. Greenfield, and Milan Bimali.
Metrics
- h-index: 34
- Publications: 97
- Citations: 31,352
Selected Publications
-
Abstract 6079: Resistance-specific proteogenomics in melanoma PDXs (2026)
-
Late-in-life treadmill training mitigates gut microbiome imbalances and cardiovascular disease risk in mice (2026)
-
A Randomized Double-Blind Placebo-Controlled Phase I/II Clinical Trial of a Human Papillomavirus Therapeutic Vaccine, PepCan, for Reducing Head and Neck Cancer Recurrence (2026)
-
Changes in gut, microbiome, and cognition after doxorubicin, cyclophosphamide, and paclitaxel chemotherapy treatment (2026)
-
Implications of cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy on hippocampal-dependent cognition and gut microbiome (2025)
-
The effect of obesity and dietary soy protein with different isoflavone levels on fecal microbial composition in lean and obese Zucker rats over 9- and 18-week periods (2025)
-
Oat bran fiber protects against radiation-induced disruption of gut barrier dynamics and mucosal damage (2025)
-
Obesity and Dietary Soy Protein With Different Isoflavone Levels Alter Fecal Microbial Composition in Zucker Rats Over 9- and 18-Week Periods (2025)
-
Fueling the fire: colonocyte metabolism and its effect on the colonic epithelia (2025)
-
MOSHPIT: accessible, reproducible metagenome data science on the QIIME 2 framework (2025)
-
A Randomized Double-Blind Phase 2 Clinical Trial Treating Cervical Intraepithelial Neoplasia 2/3 with PepCan or <i>Candida</i> (2025)
-
Gut Microbiome Diversity and Composition Changes Post Allogeneic Hematopoietic Stem Cell Transplant (AlloSCT): A Single-Center Prospective Analysis (2024)
-
Dietary soy protein reverses obesity-induced liver steatosis and alters fecal microbial composition independent of isoflavone level (2024)
-
Bioinformatics challenges for profiling the microbiome in cancer: pitfalls and opportunities (2024)
-
Soy Protein Concentrate With Low and High Isoflavones Can Reverse Non-alcoholic Fatty Liver Disease Caused by Obesity and Alter Gut Microbial Composition (2024)
Research Interests
Dr. Robeson currently focuses on the human microbiome and its relationship to nutrition and cancer therapeutics, while also contributing to the development of bioinformatics tools to aid in these studies. Dr. Robeson’s research interests center on the human cancer microbiome, which is an important and booming area of research and is in line with the current UAMS plan for NCI designation, as it has become increasingly clear that the efficacy of anticancer treatments is not only affected by host genetic and immunological factors but are also substantially mediated by the host microbiome. Microbial community dynamics, disease resistance, human health, and agricultural productivity are all highly affected, or dependent upon, microbes. Dr. Robeson’s research integrates bioinformatics, microbial ecology, and integrative multi-omics technologies, to study host-microbe interactions. Particularly those that affect human health and agricultural productivity.; Microbiome; Microbiome Data Science; Microbial Ecology; Human Microbiome; Bioinformatics; eDNA; Phylogenetics; Cancer Microbiome; Microbiome Science; Metagenomics; Host-microbe Interactions
Grants & Funding
- Melanoma Resistance Evolution Atlas (MREA) for identifying combinatorial targets to prevent and reverse MAPKi NCI Co-Investigator
- Improvement of cellular immunotherapy during dysbiosis- Resubmission NIH Co-Investigator
- Improvement of cellular immunotherapy during dysbiosis NIH/Nat. Cancer Institute Principal Investigator
- Regulation of macrophage function during acute infection with Plasmodium NIH Co-Investigator
- Understanding and Enhancing T-Cell Responses to High Risk Human Papillomaviruses-Renewal NIH Co-Investigator
- Center for Translational Pediatric Research (CTPR) NIH/NIGMS Other Key Personnel
- Obstructive Sleep Apnea Arkansas Research Alliance Co-Investigator
Collaborators
Researchers in the database who share publications
Similar Researchers
Based on overlapping research topics